MALVERN, PA — YPrime has launched its cutting-edge eCOA 7.0 SaaS platform, poised to transform the clinical trial industry. This launch reflects YPrime’s dedication to integrating advanced technology with user-centric design to expedite clinical trial processes.
Clinical trials traditionally rely on complex and labor-intensive methods to develop and test electronic Clinical Outcome Assessments (eCOAs). YPrime aims to disrupt this outdated model with its innovative, no-code, multi-tenant platform, providing a fully configurable solution that promises up to 30% faster implementations.
“Building on our foundation to improve the patient experience, YPrime eCOA 7.0 was built to enhance both the site and sponsor experience, from its user-friendly design through to a new data warehouse that enables informed decision-making,” said Mike Hughes, Chief Product Officer at YPrime. “Sponsors are looking to optimize their operations, reduce cost, and increase efficiency; YPrime’s new eCOA platform’s robust capabilities enable seamless backward compatibility to futureproof trials.”
The eCOA 7.0 platform supports both complex and straightforward studies, delivering significant benefits to patients, sites, and sponsors. Its key features include:
- Configurable and No-Code Solution for Rapid Deployment: The platform’s no-code, fully configurable nature allows for quick study launches, cutting startup times by up to 30%.
- Data Warehouse for Informed Decision-Making: With comprehensive visibility and management capabilities for trial-specific data, the platform enables sponsors to make well-informed decisions swiftly, enhancing operational efficiencies.
- Advanced Compliance Monitoring for Risk Mitigation: This functionality provides a unified view of compliance across various indications, programs, and protocols, enabling proactive issue monitoring and resolution.
- Site Performance Monitoring to Optimize Enrollment: Sponsors can assess enrollment performance across multiple sites and countries, identifying high- or underperforming areas to optimize resources. The system also monitors patient compliance, streamlining site monitoring activities and boosting trial performance.
- Consistent User Experience with a Unified Portal and Tablet Interface: A consistent interface across portal and tablet platforms ensures easy transition and efficient management without extensive retraining.
“At YPrime, we have been innovating while competitors have been integrating their legacy systems,” said Jim Corrigan, Chief Executive Officer at YPrime. “With our latest 7.0 release, YPrime offers unmatched flexibility, scalability, and efficiency, positioning us as the definitive leader in eCOA. No other eCOA company offers the depth of configurability and user-centered design that we provide, making data entry and management efficient—and user-friendly.”
The launch of eCOA 7.0 positions YPrime at the forefront of the eCOA market, offering a platform that not only accelerates clinical trial implementation but also enhances data quality and operational efficiency. This development holds the potential to significantly reduce healthcare costs and improve patient outcomes, marking a pivotal advancement in the clinical trial landscape.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.